Loading...

Home
ETF
AVXL

AVXL

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

AVXL News

Anavex Life Sciences Stock Surges 43% Year-to-Date Amid Mixed Outlook

Anavex Life Sciences to Present at Citizens Life Sciences Conference

Mar 03 2026Newsfilter

Anavex to Present at TD Cowen Health Care Conference

Feb 25 2026Newsfilter

Anavex Appoints New Board Member

Feb 23 2026Newsfilter

Anavex Life Sciences Q1 2026 Earnings Call Insights

Feb 09 2026seekingalpha

Anavex Life Sciences Q1 Earnings Beat Expectations

Feb 09 2026seekingalpha

Anavex Reports Q1 Fiscal 2026 Financial Results and Pipeline Progress

Feb 09 2026Newsfilter

Danaher Exceeds Q4 Earnings Guidance but Faces Market Skepticism

Jan 28 2026CNBC

Anavex Joins ACCESS-AD Initiative to Accelerate Alzheimer's Disease Treatment Adoption

Jan 13 2026Globenewswire

Anavex Life Sciences Faces Investigation Over Misleading Information, Stock Plummets 35.94%

Jan 09 2026PRnewswire

Anavex Life Sciences Faces Securities Fraud Investigation After 36% Stock Drop

Jan 08 2026PRnewswire

Anavex Life Sciences Faces Securities Fraud Claims as Stock Plummets 36%

Dec 30 2025Globenewswire

Anavex Shares Plunge 35.9% Following Negative EMA Vote on Drug Application

Dec 24 2025Globenewswire

Anavex Life Sciences Asks European Medicines Agency to Reassess Blarcamesine for Early Alzheimer's Therapy

Dec 18 2025Yahoo Finance

Anavex Requests EMA to Reassess Its Negative Stance on Blarcamesine for Alzheimer's Treatment

Dec 18 2025SeekingAlpha

Anavex Requests Re-examination of Blarcamesine for Alzheimer's Disease

Dec 12 2025Globenewswire